https://www.selleckchem.com/products/Y-27632.html
Crocus sativus L. (saffron) appears to own neuroprotective effects on cognitive impairment in patients with Alzheimer's disease (AD). The purpose of this work is to review evidence and mechanisms of saffron-induced therapeutic outcomes and measureable cognitive benefits in AD. The literature was reviewed, and preclinical and clinical studies were identified. In vitro and in vivo preclinical studies were selected according to these criteria 1) development of saffron pharmacological profile on biological or biophysical endpoints; 2) evalu
Respect!
Kommentar
Delen
